Compatibility of alatrofloxacin mesylate with commonly used drugs during Y-site delivery

American Journal of Health-System Pharmacy

Volumn 57, Issue 15, 2000, Pages 1437-1439

  Voytilla, Krista L ^a   Rusho, William J ^a   Tyler, Linda S ^a  

^a UNIVERSITY OF UTAH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALATROFLOXACIN; AMIKACIN; AZTREONAM; BICARBONATE; CEFTAZIDIME; CEFTRIAXONE; CYCLOSPORIN; DOBUTAMINE; DOPAMINE; DROPERIDOL; FAMOTIDINE; FENTANYL CITRATE; FUROSEMIDE; GENTAMICIN; GLYCERYL TRINITRATE; HEPARIN; KETOROLAC TROMETAMOL; LORAZEPAM; MAGNESIUM SULFATE; MIDAZOLAM; MORPHINE SULFATE; ONDANSETRON; PIPERACILLIN PLUS TAZOBACTAM; POTASSIUM CHLORIDE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TIMENTIN; TOBRAMYCIN SULFATE; UNINDEXED DRUG; VANCOMYCIN;

ARTICLE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INFORMATION; HUMAN; INJECTION SITE; POLYPHARMACY; PRIORITY JOURNAL; SYRINGE; VASCULAR ACCESS;

EID: 0034254331     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.15.1437     Document Type: Article

References (5)

1. Trovan (trovafloxacin) package insert. New York: Pfizer; 1997 Dec.
2. Mulchings SR, Rusho WJ, Tyler LS. Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery. Am J Health-Syst Pharm. 1996; 53: 2185-8.
3. Najari Z, Rusho WJ. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery. Am J Health-Syst Pharm. 1997; 54:181-4.
4. The United States pharmacopeia, 24th rev., and The national formulary, 18th ed. Rockville, MD: The United States Pharmacopeial Convention; 2000:1974-7.
5. Lumpkin MM. Food and Drug Administration public health advisory: Trovan (trovafloxacin/alatrofloxacin mesylate) interim recommendations. www.fda.gov/ cder/news/trovan/trovan-advisory.htm (accessed 1999 Jun 9).